Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Neurofascin as a novel target for autoantibody-mediated axonal injury.

Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C.

J Exp Med. 2007 Oct 1;204(10):2363-72. Epub 2007 Sep 10.

PMID:
17846150
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

B- and T-cell responses in multiple sclerosis: novel approaches offer new insights.

Hohlfeld R, Meinl E, Dornmair K.

J Neurol Sci. 2008 Nov 15;274(1-2):5-8. doi: 10.1016/j.jns.2008.07.006. Epub 2008 Aug 15. Review.

PMID:
18707694
[PubMed - indexed for MEDLINE]
3.

Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Derfuss T, Linington C, Hohlfeld R, Meinl E.

J Mol Med (Berl). 2010 Aug;88(8):753-61. doi: 10.1007/s00109-010-0632-3. Epub 2010 May 6. Review.

PMID:
20445955
[PubMed - indexed for MEDLINE]
4.

Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.

Lassmann H.

Exp Neurol. 2010 Sep;225(1):2-8. doi: 10.1016/j.expneurol.2009.10.009. Epub 2009 Oct 17. Review.

PMID:
19840788
[PubMed - indexed for MEDLINE]
5.

Restricted immune responses lead to CNS demyelination and axonal damage.

Mancardi G, Hart BA, Capello E, Brok HP, Ben-Nun A, Roccatagliata L, Giunti D, Gazzola P, Dono M, Kerlero de Rosbo N, Colombo M, Uccelli A.

J Neuroimmunol. 2000 Jul 24;107(2):178-83. Review.

PMID:
10854654
[PubMed - indexed for MEDLINE]
6.

In vitro and in vivo models of multiple sclerosis.

van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):570-88. Review.

PMID:
22583443
[PubMed - indexed for MEDLINE]
7.

Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Mars LT, Saikali P, Liblau RS, Arbour N.

Biochim Biophys Acta. 2011 Feb;1812(2):151-61. doi: 10.1016/j.bbadis.2010.07.006. Epub 2010 Jul 15. Review.

PMID:
20637863
[PubMed - indexed for MEDLINE]
Free Article
8.

Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.

Stinissen P, Raus J, Zhang J.

Crit Rev Immunol. 1997;17(1):33-75. Review.

PMID:
9034723
[PubMed - indexed for MEDLINE]
9.

Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.

Genain CP, Hauser SL.

Immunol Rev. 2001 Oct;183:159-72. Review.

PMID:
11782255
[PubMed - indexed for MEDLINE]
10.

Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.

Skundric DS.

Curr Neurovasc Res. 2005 Oct;2(4):349-62. Review.

PMID:
16181126
[PubMed - indexed for MEDLINE]
11.

Novel approaches and cutting edge immunotherapies in multiple sclerosis.

Bauman TM, Kasper LH.

Front Biosci. 2004 Sep 1;9:2302-22. Review.

PMID:
15353289
[PubMed - indexed for MEDLINE]
12.

The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.

Stefferl A, Brehm U, Linington C.

J Neural Transm Suppl. 2000;(58):123-33. Review.

PMID:
11128602
[PubMed - indexed for MEDLINE]
13.

Macrophages and neurodegeneration.

Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD.

Brain Res Brain Res Rev. 2005 Apr;48(2):185-95. Review.

PMID:
15850657
[PubMed - indexed for MEDLINE]
14.

Influence of neurosteroids on the pathogenesis of multiple sclerosis.

Leitner H.

Med Hypotheses. 2010 Aug;75(2):229-34. doi: 10.1016/j.mehy.2010.02.028. Epub 2010 Mar 12. Review.

PMID:
20227191
[PubMed - indexed for MEDLINE]
15.

Multiple sclerosis: an altered immune response or an altered stress response?

van Noort JM.

J Mol Med (Berl). 1996 Jun;74(6):285-96. Review.

PMID:
8862510
[PubMed - indexed for MEDLINE]
16.

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.

Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J.

J Mol Med (Berl). 1997 Feb;75(2):77-88. Review.

PMID:
9083925
[PubMed - indexed for MEDLINE]
17.

Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.

Ziemssen T.

J Neurol. 2005 Nov;252 Suppl 5:v38-45. Review.

PMID:
16254701
[PubMed - indexed for MEDLINE]
18.

[Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].

Jaƛkiewicz E.

Postepy Hig Med Dosw (Online). 2004;58:472-82. Review. Polish.

PMID:
15765008
[PubMed - indexed for MEDLINE]
Free Article
19.

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.

Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C.

Glia. 2001 Nov;36(2):220-34. Review.

PMID:
11596130
[PubMed - indexed for MEDLINE]
20.

Cryptic axonal antigens and axonal loss in multiple sclerosis.

DeVries GH.

Neurochem Res. 2004 Nov;29(11):1999-2006. Review.

PMID:
15662834
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk